Mercados españoles cerrados

Monument Circle Acquisition Corp. (MON)

NasdaqCM - NasdaqCM Precio en tiempo real. Divisa en USD
Añadir a la lista de favoritos
9,69-0,04 (-0,41%)
Al cierre: 4:00PM EDT
Inicia sesión para publicar un mensaje.
  • m
    mba_japan
    $MON conversation
    Why isn't the stock moving???
  • K
    Ken
    $MON conversation
    127,50 new bid
    Bayer, which has been discussing a deal with Monsanto since mid-May, said it would pay $127.50 a share for the St. Louis-based biotech seed giant, up from its previous offer of $125 a share.
  • Z
    Zd Sr
    $MON conversation
    Its up big AH! About +5.5%. Where is the news?
  • v
    vlad
    $MON conversation
    "Jim Cramer: I Think the EU Will Block Monsanto-Bayer Deal....They have to check with really good lawyers"
    Does he really think they did not check with good lawyers ? They have billions of $ and lobbyists in every country and connections in every country's government. I am sure they know what they are doing . Scrutiny is just a part of the game - government's agencies have to show that they are not payed for nothing - they have to pretend that they are against this and show some activity to the public for a month or two.
  • s
    sma
    $MON conversation
    The buyout offer will be all cash so the stock should jump into the mid 120's when announced
  • T
    Tim
    $MON conversation
    I believe a deal will get done. I think it will be $130-$131 which is less than Monsanto wants. For a couple of reasons:
    1. Stubborn German gets what he wants.
    2. Warner will loose face if he is not able to complete this deal w/ all the time and prestige invested.
    3. Monsanto will also look bad if they don't make a deal, stock will drop 15%.
    4. We are talking 10% to get a deal @$130/sh, most good business people know not to loose a deal over 10%
  • d
    daddio
    $MON conversation
    buying every 2 pt drop...104 first...now it appears i'll get my 102 JMHO sometime today...
  • T
    Tim
    $MON conversation
    deal is @ $129 all cash w/ $3B breakup fee
  • J
    Jonathan
    Keep selling folks ! Get that price down, better additional top up point for me. You know, people might not 'like' GM in Europe but it's a bit like nuclear energy - we need it. How else we going to feed another 50 billion people ? End of. This deal will go through, the first you'll know about it is when one day next year the price 'mysteriously' flies up. 2 days later it'll be confirmed. Seem it all before, easy money.
  • m
    markho1984
    $MON conversation
    Who sells MON shares for 102$ before this deal is successfully done? I can´t understand this fact in this actual share level!
    Any new informations about the deal?
  • Z
    Zachary
    $MON conversation
    So we all know that if a offer is accpeted, which will probably be between $130 and $132. What do we think the market price will be once the offer is accept? We the deal will have to be approved by the FTC in the US and EU. We saw that Sygenta's stock popped 10% recently due to the FTC approving the merger between them and Chem China. In addition, we have to consider the arbitrage price. I'm thinking that if the buyout is $131 a share, the share price itself will sit at $122 until it receives approval. Thoughts?
  • t
    tina
    $MON conversation
    My two cents for what it is worth. I do not think the regulators are going to kill the deal, there simply is not enough synergies in the two companies. If the deal gets killed it will be from the Bayer shareholders. Why does Bayer want to pay$128.00 for a $100.00 company already trading at a multiple above 40 in an industry that trades at a multiple of about 16. I have spent a week trying to figure out the stock action, it does not make any sense. What does Monsanto have that a pharma company would want? answer genetic research. Monsanto is the premier plant science company on the planet. I think if we get past the Bayer shareholder vote we will be scott free. I am long Monsanto and think that the deal will go through.
  • D
    Dukie Brown Jr.
    $MON conversation
    How's that buyout going? Where is FunFun? Where is the pot of gold at the end of the rainbow? LMAO
  • s
    spudich
    $MON conversation
    Bayer buys out monsanto for $128 Interesting the stock moving very little to the upside here in premarket. Looks like I'm forced to hold my shares till the end of next year at which time the deal is to be completed.
  • B
    Biotechbonanza
    $MON conversation
    Cramer answered a question from a caller about why MON is trading so far below the Bayer takeover price, and he answered with "the farmers will never let it happen, and they should stop wasting our time". LOL It's obvious Cramer is clueless, first about anti-trust law(minimal overlap&ample competition, and simple divestiture of a few products which have several buyers lined up) and secondly, about what farmers are concerned about regarding the deal(larger company causing slower innovation which is by far, their biggest concern) Doesn't Cramer realize that simple farm economics prevents any of the large Ag companies from raising prices on seeds/pesticides during a period where crop prices are extremely depressed and farmers can't afford it. Farmers will gladly pay for innovation which increases crop yields and reduces pesticide usage and makes sense to their bottom line.
    Cramer will look like the fool he is when this deal is completed and he's on record saying it will never happen and I will be there to call him out on it!
  • R
    Russell
    $MON conversation
    This stock is no longer worth holding for 15 months for a 20% return that may or may not even happen if either countries regulators say no.
  • s
    spudich
    $MON conversation
    Bayer says this is there final offer of $127.50 and if it is not accepted by monsanto they will not pursue a hostile takeover of monsanto. If bayer really means what they say than there will be no buyout of monsanto. No way that monsanto will sell the company to bayer for $127.50 a share plus monsanto's debt.
  • v
    vlad
    $MON conversation
    On May 12 when the first news broke out about Bayer wanting Monsanto the stock was at $90. $127.5 is over 40% premium from $90. Considering the current struggles in farming and growth perspectives for MON, I am sure if MON rejects this it will fall down to 90 and will spend another few years below this number. Then all the shareholders will be whining about the management not accepting 127.5 buyout offer. We've seen it so many times. I think MON should sell while the stock is up and world's markets are up. JMHO.
  • J
    Joseph
    $MON conversation
    Shareholders will vote in early December on the first phase of the merger. Following the results, one way or another you will see a spike on this holding. It is expected that shareholders will obviously vote in favor of the merger, considering it is now a $30 plus/share overage. Phase 2 will begin sometime after that. I saw a timeline for the approval process on-line it looked like a two year process. I will enjoy the 500/quarter dividend for the next two years. I have 1000 shares. If it drops more, I will buy another 1000.
  • B
    Biotechbonanza
    $MON conversation
    The reason why MON dropped hard this week may not have anything to do with the likelihood of the Bayer buyout being completed. MON is a major component of most Ag-related ETF's, which have been pounded since the POT-AGU merger was announced. This ETF-related selling surely could have been responsible for much of the down move over the past few days. Most Ag stocks have traded about 10% lower in a single week so MON has actually held up pretty well in comparison and should rebound quickly once the sector catches a bid. The merger is solid and should be completed. Look at the recent WSJ article mentioning the massive regulatory and financial hurdles to bring a new Agricultural product(seed,pesticide) to market-200M EUROS and 11 YEARS! Small companies simply can not handle this burden which is why they team up with or sell their companies outright to the larger players. So the ridiculous argument that this merger would reduce competition is nonsense as the governments in the EU and US are the biggest obstacles to competition and ensure that the larger companies get even larger.